Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

The Alpha Serum serves as the central plot device in Alia Bhatt's Alpha, driving the conflict between intelligence agencies ...

Ancient evidence suggests a new twist in how we all got here.

A House committee wants answers from major drugmakers about their China clinical trial practices. The deadline is tighter ...

Researchers have identified a previously overlooked mechanism of brain cell death that appears to play a major role in ...

This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

Ipsen is on a roll this week, scooping up its second biotech in three days in order to firm up its pipeline with promising clinical-stage candidates. This morning’s deal sees the French biopharma ...

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

NovaBridge (NBP) is rated Sell due to limited market opportunity, intense competition, and high cash burn overshadowing its ...

NAD+ levels fall up to 65% as we age. Learn the clinical science behind Niagen Bioscience's NAD precursor and how it fights ...

Discover the top pharma stories, from ovarian cancer and Ebola vaccines to the biotech M&A rebound and what they mean for the industry.

Scientists pieced together the genetic history of Acinetobacter baumannii — a notoriously stubborn hospital pathogen — using ...